ThomasJeffersonHeltonIVDOMBA, FACC, FSCAI

Cardiology • Kingsport, TN

Interventional Cardiology

President and CEO Ballad CVA Heart Institute

Join to view full profile

Dr. Helton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Helton's full profile

Already have an account?

Office
2050 Meadowview Pkwy
Kingsport, TN 37660
Phone+1 423-230-5000

Fax+1 423-230-5097

Education & Training

University of Tennessee Physician Executive MBA, 2023 - 2023
Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2009 - 2011
Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2006 - 2009
Cleveland Clinic FoundationResidency, Internal Medicine, 2002 - 2005
University of Pikeville Kentucky College of Osteopathic MedicineClass of 2002

Certifications & Licensure

OH State License 2004 - 2026
KY State License 2011 - 2025
TN State License 2015 - 2025
VA State License 2021 - 2024
NC State License 2013 - 2018
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Fellow (FACC) American College of Cardiology

Clinical Trials

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement Start of enrollment: 2020 Dec 19
Recruiting
Not Applicable

Publications & Presentations

PubMed

49 citations
Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials.
Thomas J. Helton, Anthony A. Bavry, Dharam J. Kumbhani, Sandeep Duggal, Henri Roukoz
American Journal of Cardiovascular Drugs. 2007-01-01
122 citations
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention: a meta-analysis
Anthony A. Bavry, Dharam J. Kumbhani, Thomas J. Helton, Deepak L. Bhatt
Journal of the American College of Cardiology. 2005-03-15
362 citations
Late Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical Trials
Anthony A. Bavry, Dharam J. Kumbhani, Thomas J. Helton, Przemyslaw P. Borek, Girish R. Mood
The American Journal of Medicine. 2006-12-01

Professional Memberships